SLC38A2 and cancer: The analysis results from the Estimate algorithm indicate that the expression of SLC38A2 is positively correlated with stromal scores in most cancer types, including BRCA, COAD, ESCA, KIRC, LIHC, LUAD, OV, PAAD, PCPG, PRAD, READ, STAD, TGCT, THCA, and UCS.